Nexstim Plc (HEL:NXTMH)

Finland flag Finland · Delayed Price · Currency is EUR
13.00
+0.10 (0.78%)
At close: Jan 30, 2026
67.96%
Market Cap93.05M +52.9%
Revenue (ttm)11.63M +24.2%
Net Income-282.99K
EPS-0.04
Shares Out7.21M
PE Ration/a
Forward PE49.62
Dividendn/a
Ex-Dividend Daten/a
Volume3,309
Average Volume9,818
Open13.00
Previous Close12.90
Day's Range12.95 - 13.15
52-Week Range6.40 - 16.45
Beta0.46
RSI46.19
Earnings DateFeb 26, 2026

About Nexstim

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NB... [Read more]

Sector Healthcare
Founded 2000
Employees 40
Stock Exchange Nasdaq Helsinki
Ticker Symbol NXTMH
Full Company Profile

Financial Performance

In 2024, Nexstim's revenue was 10.21 million, an increase of 18.97% compared to the previous year's 8.58 million. Losses were -892,285, -32.79% less than in 2023.

Financial Statements